Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-06-22 17:11 Tx date 2023-06-19 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$143,880
+33,000 vol $4.36 each |
104,197 | |
Filed 2023-06-22 17:09 Tx date 2023-06-19 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$347,750
+25,000 vol $13.91 each |
71,197 | |
Filed 2023-06-22 17:08 Tx date 2023-06-19 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$120,996
+27,777 vol $4.36 each |
46,197 | |
Filed 2023-06-22 17:07 Tx date 2023-06-19 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-143,880
-33,000 vol $4.36 each |
152,334 | |
Filed 2023-06-22 17:06 Tx date 2023-06-19 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-347,750
-25,000 vol $13.91 each |
185,334 | |
Filed 2023-06-22 17:05 Tx date 2023-06-19 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-120,996.612
-27,777 vol $4.36 each |
210,334 | |
Filed 2023-03-23 21:08 Tx date 2023-03-21 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,000 vol |
238,111 | |
Filed 2022-06-02 13:11 Tx date 2022-05-31 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$53,996
+5,228 vol $10.33 each |
60,959 | |
Filed 2022-02-25 22:27 Tx date 2022-02-23 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
214,111 | |
Filed 2021-06-01 17:06 Tx date 2021-05-31 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$63,002
+13,615 vol $4.63 each |
55,731 | |
Filed 2021-03-01 19:22 Tx date 2021-02-25 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+33,000 vol |
169,111 | |
Filed 2020-06-12 17:33 Tx date 2020-06-10 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,034
+3,800 vol $13.43 each |
18,420 | |
Filed 2020-06-02 19:51 Tx date 2020-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$131,100
+10,000 vol $13.11 each |
35,000 | |
Filed 2020-06-01 16:59 Tx date 2020-05-31 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$72,004
+4,960 vol $14.52 each |
42,116 | |
Filed 2020-04-01 18:06 Tx date 2020-04-01 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
136,111 | |
Filed 2020-01-14 15:11 Tx date 2020-01-13 |
$XENE
Xenon Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
25,000 | |
Filed 2020-01-14 15:07 Tx date 2020-01-13 |
$XENE
Xenon Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-08-20 17:00 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-288,889 vol |
111,111 | |
Filed 2019-08-20 16:59 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
37 - Stock split or consolidation
|
-96,604 vol |
37,156 | |
Filed 2019-08-20 16:58 Tx date 2019-08-15 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-38,012 vol |
14,620 | |
Filed 2019-05-31 14:28 Tx date 2019-05-31 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$45,000
+30,858 vol $1.46 each |
133,760 | |
Filed 2019-04-22 10:15 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-1,657,757 vol |
0 | |
Filed 2019-04-22 10:14 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-20,351,350
-814,054 vol $25.00 each |
0 | |
Filed 2019-04-10 12:20 Tx date 2019-04-09 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+814,054 vol |
814,054 | |
Filed 2019-04-10 12:20 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 3669661 Canada Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-04-10 12:19 Tx date 2019-04-09 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-814,054 vol |
0 | |
Filed 2019-02-21 Tx date 2019-02-20 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
400,000 | |
Filed 2019-02-21 Tx date 2019-02-18 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+463,300 vol |
1,657,757 | |
Filed 2018-12-18 Tx date 2018-12-18 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,000
+52,632 vol $0.95 each |
52,632 | |
Filed 2018-12-18 Tx date 2017-09-27 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-05-31 Tx date 2018-05-31 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$45,000
+78,603 vol $0.57 each |
102,902 | |
Filed 2018-04-20 Tx date 2018-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,194,457 | |
Filed 2018-03-16 Tx date 2018-03-15 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$11,250
+24,299 vol $0.463 each |
24,299 | |
Filed 2018-03-16 Tx date 2017-09-27 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-02 Tx date 2018-02-27 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+305,000 vol |
1,094,457 | |
Filed 2018-02-23 Tx date 2018-02-20 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
300,000 | |
Filed 2017-11-09 Tx date 2017-09-27 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-11-09 Tx date 2017-11-07 |
$BLU
BELLUS Health Inc. |
Desjardins, Clarissa
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
789,457 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Desjardins, Clarissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
814,054 |